For the Inventor, By the Inventor

Enter assignee name

Luxembourg, Luxembourg

Mitotech Sa

USPTO Granted Patents = 17

CIPO Patents = 3

EPO Patents = 4

Trademarks = 1

Forward Citations = 15

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Maxim Vladimirovich Skulachev (16 out of 21 patents)

Vladimir Petrovich Skulachev (15 out of 15 patents)

Maxim Viktorovich Egorov (4 out of 4 patents)

4. Roman A Zinovkin (3 out of 3 patents)

5. Vadim N Tashlitsky (3 out of 3 patents)

6. Dmitry Borisovich Zorov (2 out of 2 patents)

7. Lawrence Friedhoff (2 out of 9 patents)

8. Olga Y Pletushkina (2 out of 2 patents)

9. Alexander A Andreev-Andrievsky (2 out of 2 patents)

10. Tatiana V Zinevich (2 out of 2 patents)

11. Nikolai Konstantinovich Isaev (1 out of 1 patent)

12. Fedor Fedorovich Severin (1 out of 1 patent)

13. Elena Viktorovna Stelmashuk (1 out of 1 patent)

14. Nadezhda Anatolievna Kapay (1 out of 1 patent)

15. Egor Y Plotnikov (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 10213392 - Pharmaceutical composition for use in medical and veterinary ophthalmology (2019-02-26),

2. 10188669 - Mitochondria-targeted antioxidants for treatment of age-related brain disorders (2019-01-29),

3. 9744180 - Pharmaceutical formulations containing mitochondrially targeted antioxidants (2017-08-29),

4. 9724313 - Pharmaceutical composition for use in medical and veterinary ophthalmology (2017-08-08),

5. 9572890 - Oral formulations of mitochondrially-targeted antioxidants and their preparation and use (2017-02-21),

6. 9572821 - Pharmaceutical compositions for preventing and treating eye pathologies (2017-02-21),

7. 9439916 - Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition (2016-09-13),

8. 9427444 - Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages (2016-08-30),

9. 9408859 - Pharmaceutical compositions useful for preventing and treating cancer (2016-08-09),

10. 9328130 - Method of treating organism by biologically active compounds specifically delivered into mitochondria, pharmaceutical composition required for the use of the method and a compound applicable for this purpose (2016-05-03),

11. 9308214 - Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations (2016-04-12),

12. 9233903 - Pharmaceutical substances on the basis of mitochondria-addressed antioxidants (2016-01-12),

13. 9192676 - Oral formulations of mitochondrially-targeted antioxidants and their preparation and use (2015-11-24),

14. 8658624 - Pharmaceutical compositions for preventing and treating eye pathologies (2014-02-25),

15. 8557733 - Composition for regenerating and stimulating growth of plants and for adapting plants to different stress factors (2013-10-15),

Mitotech is a leading biotechnology company specializing in the development of innovative pharmaceuticals and diagnostics in the fields of ophthalmology and neurodegenerative diseases. With a focus on mitochondrial medicine, Mitotech aims to address unmet medical needs and improve patients' quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

17 Patents

#42 in Luxembourg

#60 in Luxembourg

#34,919 in the World

Luxembourg, Luxembourg

Mitotech Sa

Forward Citations = 15

29 inventors:

Maxim Vladimirovich Skulachev (16 out of 21 patents)

Vladimir Petrovich Skulachev (15 out of 15 patents)

Maxim Viktorovich Egorov (4 out of 4 patents)

4. Roman A Zinovkin (3 out of 3 patents)

5. Vadim N Tashlitsky (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…